Sign in / Join Now
ETFs & Funds
Back from vacation; last week booked gains on trading blocs of
; still holding
; keeping my 60% cash position 4 short term trades
and still holding 40% in quality high yielder energy players e.g.
; and select holdings on the Oslo and Australian xchanges
Reduced all div plays by 50% this morning.Looking 4 a much better re-entry point in next few months ! Welcome back ! pura vida.. (10.57 am)
Thx DaL -- Agree w/ you + Pok; expect a few bargains over coming months; no fundamental changes but mkt keeps gorging on headline hopium.
"headline hopium" 100% perfect sum up.But,truth b told that hopium points 2 bad things in reality.$$$? when does reality b come reality !
Add a reply...
Latest StockTalks »
people get BMY breaking news and analysis by email alert.
Get email alerts on BMY »
Bristol-Myers Squibb Company
Get latest price
From other sites
U.S. Food And Drug Administration Accepts For Priority Review The Supplemental Biologics License Application For Opdivo (nivolumab) In Previously Treated Patients With Advanced Form Of Bladder Cancer
at TheStreet (Fri, 2:19PM)
Bristol-Myers Squibb Updates Conference Call Dial-in/ID For Third Quarter 2016 Results On October 27
at TheStreet (Fri, 11:03AM)
Bristol-Myers Squibb (BMY) Q3 Earnings: What's in Store?
at Zacks.com (Fri, 9:26AM)
Bristol-Myers Squibb Foundation Joins White House Cancer Moonshot
at TheStreet (Mon, 12:15PM)
Bristol-Myers Squibb Receives Positive CHMP Opinion For Opdivo (nivolumab) For The Treatment Of Adult Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant And Treatment With Brentuximab Vedotin
at TheStreet (Oct 14, 2016)